Mark Clemons is a Clinician Scientist at the Ottawa Hospital Research Institute (Cancer Therapeutics Program), staff medical oncologist (Ottawa Hospital Cancer Centre) and Professor of Medicine (University of Ottawa). He is the recipient of multiple peer-reveiwed research grants and has over 350 publications in the field of breast cancer management. His research vision is to remove many of the barriers that lead the development of multiple standard of care therapies with very little data to actually show which treatment is best in the real world setting. This has resulted in the creation of the world’s largest, pragmatic oncology trials program (REthinking Clinical Trials: REaCT) which to date has accrued over 5500 patients from across Canada.